A survey found that 53% of dog owners expressed some hesitancy about their pet's vaccines, which can prevent fatal diseases like rabies.
The CDC's advisory committee recommended this month that adults over 60 can receive one of two RSV vaccines, setting the stage for wide distribution this year.
The NIH announced the start of a new phase I trial of a potential universal flu vaccine, which uses mRNA technology.
Health officials in Chicago are reporting a resurgence of the viral disease formerly known as monkeypox.
In a large Phase III trial, GlaxoSmithKline's Arexvy substantially reduced people's risk of severe complications from respiratory syncytial virus infection.
House members advanced a bill that would bar covid-19 vax mandates, and also ensure the public isn't forcibly subjected to microchipping or genetic mutation.
Research found a link between little sleep and a poorer response to vaccines, though more work is needed to understand the connection.
A novel treatment should train the immune system to target breast cancer. It's shown major promise in a 10-year-long clinical trial.
In animal experiments, the vaccine prevented severe infections and deaths from three fungi that regularly sicken people.
In a bid to simplify its advice, the agency is aiming to make covid-19 vaccination similar to the yearly flu shot.
In people over 60, the mRNA-based vaccine appeared over 80% effective at preventing symptoms linked to lower respiratory infections caused by the virus.
Most cases have occurred in unvaccinated children, many of whom were eligible for the highly effective shots.
If this research continues to pan out, scientists may be able to provide lasting protection against other diseases like hepatitis C, flu, and covid-19.
Satanic ingredients, mass death, and other debunked talking points from the anti-vaccination movement.
The outbreak has sickened at least 18 children to date, all of whom were unvaccinated.
New reporting reveals the Department of Homeland Security's ongoing efforts to police "dangerous" and subversive ideas on the internet. What could go wrong?
A new analysis from the Commonwealth Fund predicts that even a modest booster campaign would save tens of thousands of lives and billions in medical costs.
Anti-vaxxers dig in their heels when challenged with facts and are more likely to soften their opinion through exposure to relatable, empathetic stories.
The new generation of boosters, which protect against the latest Omicron variants as well as the original coronavirus, will likely be available within weeks.
The Massachusetts-based company claims that Pfizer and BioNTech lifted two key pieces of its mRNA vaccine platform without proper compensation.
